Last reviewed · How we verify
NCT06686303
Effects of Combined Segmental Vibrator and Neuromuscular Electrical Stimulation in Subacute Stroke
NA trial testing High frequency Segmental Vibrator in Subacute Stroke in 50 participants. Completed in 5 December 2024.
5 December 2024
Quick facts
| Lead sponsor | Riphah International University |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | single |
| Primary purpose | treatment |
| Enrollment | 50 |
| Start date | 1 January 2024 |
| Primary completion | 5 December 2024 |
| Estimated completion | 5 December 2024 |
| Sites | 1 location across Pakistan |
Drugs / interventions tested
- High frequency Segmental Vibrator
- Combined effects of high frequency segmental vibrator and neuromuscular electrical stimulation.
Conditions studied
- Subacute Stroke — all drugs for Subacute Stroke →
Sponsor
Riphah International University
Who can join
Adults 45 to 65, any sex, with Subacute Stroke. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Stroke is leading cause of death and disability worldwide, resulting in significant functional limitations and disabilities experienced by stroke survivors, particularly in the upper limb. There is a need for more effective interventions targeting upper limb sensory motor impairments. The aim of this study is to study combined effect of segmental vibrator and neuromuscular electrical stimulation for flexor and extensor muscle groups on upper limb function in sub-acute stroke.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT06686303
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Subacute Stroke
Currently open trials in the same condition.
- NCT07469163 — Phase I Split-Belt Treadmill Dosing for Subacute Stroke · Phase 1 · recruiting
- NCT07236216 — Effects of tES Combined With CMDT Gait Training on Cognition, Cortical Activity, Spinal Motoneuron Excitability and Moto · NA · recruiting
- NCT07353203 — Safety and Efficacy of Hip Assist Powered Exoskeleton for Gait Training in Patients With Late Subacute and Chronic Strok · NA · recruiting
- NCT06752707 — MiGo Tracker Remote Monitoring of Home Exercise After Stroke · NA · recruiting
- NCT06972355 — Efficacy of Treadmill Walking With Hidden Vision for Rehabilitation in the Subacute Phase of Stroke · NA · recruiting
Other Riphah International University trials
Trials by the same sponsor.
- NCT07579585 — Effects of Photobiomodulation in Hemophilia Patients. · NA · recruiting
- NCT07504276 — Tele-Rehabilitation vs Conventional Rehabilitation for Cognitive Improvement in Stroke Survivors. · NA · recruiting
- NCT07484477 — Sedentary Behavior Modification, Cardiopulmonary Function & QOL Post Cardiac Surgery Patients. · NA · not yet recruiting
- NCT07438587 — Comparative Effects of Cadence Training vs Elliptical Training in Cricketers · NA · not yet recruiting
- NCT07484399 — Comparing Effects of HIIT and MICT on Functional Mobility, Muscle Strength, and Quality of Life in Diabetic Patients · NA · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06686303 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Riphah International University
- Last refreshed: 9 April 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06686303.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing